Affiliation: Lankenau Institute for Medical Research
- Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approachLouis E Samuels
Department of Surgery, Division of Cardiothoracic Surgery, Lankenau Medical Center, Wynnewood, PA, USA
J Cardiothorac Surg 7:21. 2012..The purpose of this report is to describe an alternative implantation approach for the implantation of the Heartmate II™ LVAD in high risk DT patients...
- Cardiogenic shock associated with loco-regional anesthesia rescued with left ventricular assist device implantationLouis E Samuels
Department of Cardiothoracic Surgery, Lankenau Hospital, Wynnewood, PA, USA
J Cardiothorac Surg 5:126. 2010..Twenty-four hours later, cardiac function normalized and the LVAD was removed. The patient was discharged five days later and remained with normal heart function in three-year follow-up...
- Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapyChristopher Droogan
Department of Cardiology, Main Line Health Heart Center and Lankenau Hospital, 100 Lancaster Avenue, MOBE 356, Wynnewood, PA 19096, USA
Heart Fail Clin 7:195-205, viii. 2011..This article describes data supporting the need for and potential risks and benefits of adjuvant antiarrhythmic drug therapy and examines the benefits and pitfalls of the same in ICD-implanted patients...